Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
20/07/2026 21:42
BRIEF-Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) July 20 (Reuters) - Rani Therapeutics Holdings Inc RANI.O:
RANI THERAPEUTICS REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nGNX4B2f4J
Further company coverage: RANI.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Holdings, Inc reports results for the quarter ended September 30 - Earnings Summary
Rani Therapeutics Q3 net loss widens on higher R&D costs
Rani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics